These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9678133)

  • 21. The truth about oral contraceptives and venous thromboembolism.
    Shulman LP; Goldzieher JW
    J Reprod Med; 2003 Nov; 48(11 Suppl):930-8. PubMed ID: 14686030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
    Jick SS; Jick H
    Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical experience with the recently developed progestogens.
    Skouby SO; Petersen KR
    Int J Fertil; 1991; 36 Suppl 1():32-7. PubMed ID: 1678379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Third generation oral contraceptives containing desogestrel and gestodene and the risk of thrombosis.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1996 Mar; 15(1):5-7. PubMed ID: 8920631
    [No Abstract]   [Full Text] [Related]  

  • 25. [Contraceptive agents and risk of thrombosis].
    Maurer-Major E; Keller PJ
    Praxis (Bern 1994); 1997 Oct; 86(40):1543-8. PubMed ID: 9417570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Oral contraceptive pill and thrombotic risk: epidemiological studies].
    Fruzzetti F; Perini D; Spirito N; Manca R
    Minerva Ginecol; 2012 Dec; 64(6):539-49. PubMed ID: 23232538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral contraceptives, hormone therapy and cardiovascular risk.
    Shapiro S
    Climacteric; 2008 Oct; 11(5):355-63. PubMed ID: 18781479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral contraceptive pills and the risk of venous thromboembolism.
    Prog Hum Reprod Res; 1996; (39):2-3. PubMed ID: 12292198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Risk of thromboembolism and oral contraceptives].
    Lê MG
    Contracept Fertil Sex; 1996 May; 24(5):378-83. PubMed ID: 8704816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effects of oral estrogen-progestin contraceptives on blood coagulation and assessment of the risk of thromboembolism].
    Surico N; Porcelli A; Petrelli P; Amedeo M; Crivello T; Ferraris G
    Minerva Ginecol; 1988 Sep; 40(9):559-62. PubMed ID: 2975773
    [No Abstract]   [Full Text] [Related]  

  • 31. Comments on desogestrel and gestoden (3rd generation progestogens) and the incidence of thromboembolism.
    Lauritzen C
    Horm Metab Res; 1996 May; 28(5):245-7. PubMed ID: 8738115
    [No Abstract]   [Full Text] [Related]  

  • 32. Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
    Odlind V; Milsom I; Persson I; Victor A
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):482-90. PubMed ID: 12047300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombotic diseases in young women and the influence of oral contraceptives.
    Lidegaard O
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S; Meijers JC; van den Ende AE; van Enk A; Bouma BN; Tans G; Rosing J; Prins MH; Büller HR
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What does the micropill bring?].
    Mall-Haefeli M
    Ther Umsch; 1986 May; 43(5):365-71. PubMed ID: 2941889
    [No Abstract]   [Full Text] [Related]  

  • 36. Oral contraceptives and the risk of DVT.
    Piegsa K; Guillebaud J
    Practitioner; 1996 Sep; 240(1566):544-51. PubMed ID: 8984464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraception and thromboembolism: the role of progestogens.
    N Z Med J; 1980 Aug; 92(665):98, 101. PubMed ID: 6933346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
    Cole JA; Norman H; Doherty M; Walker AM
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
    Lidegaard Ø; Nielsen LH; Skovlund CW; Skjeldestad FE; Løkkegaard E
    BMJ; 2011 Oct; 343():d6423. PubMed ID: 22027398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of acute myocardial infarction and low-dose combined oral contraceptives.
    Jick H; Jick S; Myers MW; Vasilakis C
    Lancet; 1996 Mar; 347(9001):627-8. PubMed ID: 8596366
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.